Preview Mode Links will not work in preview mode

Nov 7, 2022

Featuring a slide presentation and related discussion from Dr Rebecca Heist, including the following topics:

  • Targeting MET exon 14 skipping mutations in non-small cell lung cancer (NSCLC) (0:00)
  • Efficacy and tolerability of MET tyrosine kinase inhibitors in patients with NSCLC and MET alterations (12:35)
  • Mechanisms of resistance to therapies for MET-altered NSCLC (19:11)
  • Evaluating the role of antibody-based therapy in the treatment of MET-altered NSCLC  (25:17)

CME information and select publications